Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
The plant will drive pharmaceutical innovation in the Northeastern India
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
Revenue from Operations stood at Rs. 2,607 crore, 25% YoY growth. Domestic revenue at Rs. 2,400 crore, 20% YoY growth and export revenue at Rs. 207 crore, 118% YoY growth
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
Subscribe To Our Newsletter & Stay Updated
